Latest News for: carcinoma

Edit

Medivir receives European patent for fostrox plus lenvatinib in treatment of hepatocellular carcinoma (HCC) and cancer metastases in the liver (Medivir AB)

Public Technologies 19 Mar 2025
2025-03-19 09.15.00 CET Medivir AB - Investor News Medivir receives European patent for fostrox plus lenvatinib in treatment of hepatocellular carcinoma (HCC) and cancer metastases in the liver ... A global view of hepatocellular carcinoma.
Edit

Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China

PR Newswire 19 Mar 2025
... renal cell carcinoma ... "The positive results from this Phase 3 study of the sintilimab and fruquintinib combination represent a significant advancement in the treatment of advanced renal cell carcinoma.
Edit

Count Me In Launches New Patient-Partnered Research Project for Translocation Renal Cell Carcinoma

PR Newswire 11 Mar 2025
... the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute, is launching a new project focused on translocation renal cell carcinoma (tRCC), a rare and aggressive form of kidney cancer.
Edit

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

PR Newswire 06 Mar 2025
... PD-1/CTLA-4 bispecific antibody independently developed by the company, as an adjuvant treatment for hepatocellular carcinoma (HCC) with high recurrence risk following curative resection or ablation.
Edit

Merkel Cell Carcinoma Market is Expected to Advance at a CAGR of 8.7% During the ...

GetNews 06 Mar 2025
Among the EU4 and the UK, Germany held the largest Merkel Cell Carcinoma market share, followed by France. Download the report to understand which factors are driving the Merkel Cell Carcinoma therapeutic market @ .
Edit

Head and Neck Squamous Cell Carcinomas Market to Expand Significantly by 2034 Across APAC Region, ...

GetNews 06 Mar 2025
The Key Head and Neck Squamous Cell Carcinomas Companies in the marlet include - M.D ... To Know in detail about the Head and Neck Squamous Cell Carcinomas market outlook, drug uptake, treatment scenario and epidemiology trends, Click here;.
Edit

Adrenocortical Carcinoma Treatment Market Size in the 7MM reached approximately ~USD 22.4 million in 2023, ...

GetNews 05 Mar 2025
bladder or upper tract carcinoma with variant histology, adrenocortical carcinoma, other rare genitourinary carcinomas, and any genitourinary carcinoma with neuroendocrine differentiation ... Adrenocortical Carcinoma Epidemiology Segmentation in the 7MM.
Edit

Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies At The Horizon Expected ...

MENA FN 04 Mar 2025
(MENAFN - GlobeNewsWire - Nasdaq) The advanced urothelial carcinoma market is witnessing significant growth, driven by an aging population and the rising prevalence of metastatic cases. Advances in ... .
Edit

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination ...

The Milton Standard Journal 04 Mar 2025
SAN MATEO, Calif.--(BUSINESS WIRE)--Mar 4, 2025-- ....
Edit

Metastatic Merkel Cell Carcinoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 04 Mar 2025
... cancer, Merkel cell carcinoma and squamous cell carcinoma of the anal canal (SCAC); and in combination with platinum-based chemotherapy for patients with non-small cell lung cancer and SCAC.
Edit

Merkel Cell Carcinoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 04 Mar 2025
DelveInsight’s, “Merkel Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 14+ companies and 14+ pipeline drugs in Merkel Cell Carcinoma pipeline landscape ... Merkel Cell Carcinoma Companies.
Edit

Kidney Cancer: Understanding What a Renal Cell Carcinoma Diagnosis Means

Mega Doctor News 03 Mar 2025
Renal cell carcinoma is the most common form of kidney cancer ... Newswise — ROCHESTER, Minnesota — Renal cell carcinoma is the most common form of kidney cancer ... Renal cell carcinoma typically develops as a single tumor in one kidney.
Edit

Advanced Renal Cell Carcinoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ...

GetNews 03 Mar 2025
DelveInsight’s, “Advanced Renal Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape.
  • 1

Article Search

tools
×
×
×
×